Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
C. Light Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
C. Light Technologies

C. Light Technologies

C. Light Technologies develops retinal eye-tracking platforms for enhanced neurodegenerative disease monitoring.

HQ
Berkeley, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

C. Light Technologies develops retinal eye-tracking platforms to enhance the monitoring of neurodegenerative diseases. Their flagship product, Retitrack™, is the first compact, FDA-cleared retinal-tracking monitor that measures saccades and fixation, providing detailed analytics on eye movement metrics such as speed, magnitude, and accuracy.

C. Light Technologies has achieved significant milestones, including FDA (k) clearance for Retitrack™, which underscores its pioneering role in neurotech. The company's innovative approach to eye-tracking technology offers advanced tools for medical professionals to better assess and manage neurodegenerative conditions.

C. Light Technologies - Similar Companies

Luminopia logo

Luminopia

luminopia.com

International Light Technologies logo

International Light Technologies

intl-lighttech.com

2C Tech logo

2C Tech

Blinktbi logo

Blinktbi

blinktbi.com

Blink Technologies logo

Blink Technologies

Retina Technologies logo

Retina Technologies

Photopharmics logo

Photopharmics

photopharmics.com

EyeTech Digital Systems logo

EyeTech Digital Systems

eyetechds.com

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

ClearLight Biotechnologies logo

ClearLight Biotechnologies

Pcube-Lab logo

Pcube-Lab

neuroclues.com

Lygent logo

Lygent

i-Lumen Scientific logo

i-Lumen Scientific

i-lumen.com

Lightengale logo

Lightengale

EyeCyte logo

EyeCyte

eyecyte.com

C. Light Technologies - Quick Facts

Who are C. Light Technologies' competitors?

Companies similar to C. Light Technologies include Luminopia, International Light Technologies, 2C Tech and Blinktbi.

When was C. Light Technologies founded?

C. Light Technologies was founded in 2014.

Where is C. Light Technologies' headquarters located?

C. Light Technologies' headquarters is located in Berkeley, CA, US.

When was C. Light Technologies' last funding round?

C. Light Technologies' most recent funding round was for $251k (USD) in August 2021.

How much has C. Light Technologies raised to-date?

As of Aug 4, 2021, C. Light Technologies has raised a total of $5.1M (USD).

How many employees does C. Light Technologies have?

C. Light Technologies has 13 employees as of Feb 4, 2024.

C. Light Technologies - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software